Skip to Content

Value The Markets

Stock Market Review for the Retail Investor

Tag

Open Orphan

VIDEO: Open Orphan’s Cathal Friel on pharma services firm’s plans and COVID-19 work (piworld) (ORPH)
17 Mar 2020
Open Orphan one step closer to breakthrough universal flu vaccine as Phase 3 trials proceed (ORPH)
10 Mar 2020
Open Orphan’s Cathal Friel on firm’s “milestone” human coronavirus challenge study (ORPH)
09 Mar 2020
Open Orphan signs £3.2m challenge study deal with upside potential (ORPH)
06 Mar 2020
Open Orphan primed to support coronavirus vaccine work after bringing in world-leading experts (ORPH)
27 Feb 2020
Open Orphan brings in hVIVO founder Prof. John Oxford to head up coronavirus committee (ORPH)
20 Feb 2020
The Shifting Shares review of this year’s Growth and Innovation Forum (Part 2/2)
17 Feb 2020
VIDEO: Open Orphan’s Cathal Friel details ambitious 2020 plans following £5.3m raise in exclusive presentation (ORPH)
12 Feb 2020
Open Orphan expects profits within months as it plans role in coronavirus treatment (ORPH)
05 Feb 2020
Cathal Friel reiterates his full-time executive commitment to Open Orphan as hVIVO merger advances (ORPH)
06 Jan 2020
Open Orphan signs key contract with Pennsylvania’s SFA Therapeutics (ORPH)
18 Dec 2019
Open Orphan signs five clients to Genomic Health Data platform ahead of launch (ORPH)
25 Nov 2019
ValueTheMarkets Podcast 032 – with Maurice Treacy, Chief Commercial Officer of Open Orphan (ORPH)
22 Nov 2019
Open Orphan announces second deal in a week – hear more on the ValueTheMarkets podcast (ORPH)
19 Nov 2019
ValueTheMarkets Podcast 030 – with Cathal Friel, CEO of Open Orphan (ORPH)
18 Nov 2019
Open Orphan signs key agreement with major biopharma player (ORPH)
11 Nov 2019
VIDEO: Open Orphan’s Maurice Treacy details pharma services firm’s ambitious growth plans in exclusive ValueTheMarkets presentation (ORPH)
31 Oct 2019
EXCLUSIVE WEBINAR: Open Orphan to discuss its ambitious plans for high growth in the pharma services market (ORPH)
29 Oct 2019
Open Orphan – Consolidating the fragmented pharma services market (ORPH)
15 Oct 2019

teathers app screenshot

App Empowering Private Investors

Crowd Equity for Placings, IPOs and Live Market Blockbuilds, designed to give provate investors access to placements and Intial Public Offerings (IPOs), predominantly on the London Stock Exchange’s Alternative Investment Market (AIM).